<div id="readability-page-1"><p>Sara Bay Financial purchased a new stake in  ASP Isotopes Inc. (NASDAQ:ASPI - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor  purchased 903,103 shares of the company's stock, valued at approximately $8,688,000. ASP Isotopes makes up  about  2.4% of Sara Bay Financial's portfolio, making the stock its 10th largest position. Sara Bay Financial owned about 0.98% of ASP Isotopes as of its most recent SEC filing.</p><p>A number of other hedge funds also recently modified their holdings of ASPI. B. Riley Wealth Advisors Inc. acquired a new stake in shares of  ASP Isotopes during the 2nd quarter worth approximately $121,000.  Marex Group plc acquired a new position in shares of  ASP Isotopes in the second quarter valued at $552,000.  FORA Capital LLC bought a new position in  ASP Isotopes in the second quarter worth $107,000.  Tower Research Capital LLC TRC lifted its position in  ASP Isotopes by 96.7% in the second quarter. Tower Research Capital LLC TRC now owns 10,890 shares of the company's stock worth $80,000 after purchasing an additional 5,353 shares during the period.  Finally, Shay Capital LLC acquired a new stake in  ASP Isotopes during the second quarter worth $320,000. Institutional investors own  16.80% of the company's stock. </p><h2>Insiders Place Their Bets</h2><p>In other news, Chairman Paul Elliot Mann sold 162,153 shares of the firm's stock in a transaction that occurred on Monday, December 1st. The shares were sold at an average price of $5.75, for a total transaction of $932,379.75. Following the completion of the sale, the chairman owned 7,759,538 shares of the company's stock, valued at approximately $44,617,343.50. This trade represents a 2.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Robert Ainscow sold 8,438 shares of the business's stock in a transaction that occurred on Monday, December 8th. The stock was sold at an average price of $6.20, for a total value of $52,315.60. Following the completion of the transaction, the chief executive officer directly owned 1,546,255 shares in the company, valued at $9,586,781. The trade was a 0.54% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 512,091 shares of company stock valued at $3,699,245. 14.40% of the stock is currently owned by insiders. </p><h2>Analyst Ratings Changes</h2><p>Several equities research analysts have issued reports on the stock. Weiss Ratings  reissued a &#34;sell (d-)&#34; rating on shares of ASP Isotopes in a report on Monday, December 15th. Cantor Fitzgerald initiated coverage on shares of ASP Isotopes in a research report on Thursday, December 4th. They set an &#34;overweight&#34; rating and a $13.00 target price on the stock. Canaccord Genuity Group  reissued a &#34;buy&#34; rating and issued a $11.00 target price on shares of ASP Isotopes in a research note on Monday, November 24th. Finally, Loop Capital  set a $15.00 price target on shares of ASP Isotopes in a research note on Monday, October 27th. Two analysts have rated the stock with a Buy rating and one  has issued  a Sell rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of &#34;Hold&#34; and an average price target of $13.00.</p><p><b>Get Our Latest Stock Analysis on ASP Isotopes</b></p><h2>ASP Isotopes Stock Up 5.0%</h2><p>Shares of NASDAQ ASPI opened at $6.08 on Friday. The stock has a market cap of $673.91 million, a PE ratio of -4.68 and a beta of 3.41. The business has a fifty day moving average of $8.03 and a two-hundred day moving average of $8.63. ASP Isotopes Inc. has a 52-week low of $3.65 and a 52-week high of $14.49. The company has a debt-to-equity ratio of 1.04, a quick ratio of 6.10 and a current ratio of 6.14. </p><p>ASP Isotopes (NASDAQ:ASPI - Get Free Report) last posted its earnings results on Wednesday, November 19th. The company reported ($0.15) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.05). The firm had revenue of $4.89 million during the quarter, compared to the consensus estimate of $2.25 million. ASP Isotopes had a negative return on equity of 190.44% and a negative net margin of 1,259.12%. As a group, equities research analysts expect that  ASP Isotopes Inc. will post -0.24 earnings per share for the current fiscal year. </p><h2>About ASP Isotopes</h2> (Free Report)<p>ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.</p><h2>Recommended Stories</h2><ul><li>Five stocks we like better than ASP Isotopes</li><li>Canadian Penny Stocks: Can They Make You Rich? </li><li>These 3 Banks Are Rallying Into Year-End, But Will It Continue?</li><li>How is Compound Interest Calculated?</li><li>3 Surging Stocks Just Got the Ultimate Stamp of Approval From the S&amp;P 500</li><li>Why is the Ex-Dividend Date Significant to Investors?</li><li>This ETF Caught a Major Tailwind After the Fed’s Rate Cut</li></ul><p><strong>Want to see what other hedge funds are holding ASPI?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ASP Isotopes Inc. (NASDAQ:ASPI - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVNQSQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVNQSQ"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in ASP Isotopes Right Now?</h2><p>Before you consider ASP Isotopes, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ASP Isotopes wasn't on the list.</p><p>While ASP Isotopes currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

ASPI

<p>Sara Bay Financial acquired 903,103 shares of ASP Isotopes Inc., valued at $8,688,000, making it 2.4% of their portfolio. This purchase makes ASP Isotopes their 10th largest position. Institutional investors own 16.80% of the company's stock. Recent insider sales and analyst ratings are also noted, with a mixed outlook on the stock's performance.</p>

903,103 Shares in ASP Isotopes Inc. $ASPI Purchased by Sara Bay Financial